Global Radiotherapy Market Outlook, 2031
The Global Radiotherapy Market is segmented into By Therapy Type (External Beam Radiotherapy, Internal / Brachytherapy, Systemic Radiotherapy); By Offering (Radiotherapy Systems/Equipment, Software & Services); By Technology (Image-Guided Radiotherapy, Intensity-Modulated Radiotherapy, Stereotactic Radiosurgery, Proton Beam Therapy, 3D-Conformal Radiotherapy, Volumetric Modulated Arc Therapy, Other Technology); By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Central Nervous System / Brain, Gastro-intestinal, Other Applications); By End User (Hospitals & Integrated Cancer Centers, Standalone Radiotherapy Centers, Academic/Research Institutions, Other Healthcare Facilities).
- Bonafide Research
- 24-08-2026
- Pages : 223
- Figures : 36
- Tables : 138
- Region : Global
- Category : Lifescience & Healthcare
- Medical Devices
- Schedule a Call
-
Sikandar Kesari — Research Analyst
The Global Radiotherapy market was valued at more than USD 8.98 Billion in 2025, and expected to reach a market size of more than USD 14.07 Billion by 2031
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Market Size (2025) USD 8.98 Billion
- Market Size (2031) USD 4.24 Billion
- CAGR (2026-2031) 7.97%
- Largest MarketNorth America
- Fastest Market Asia-Pacific
- Format
Featured Companies
- 1. Sumitomo Heavy Industries
- 2. Siemens Healthineers
- 3. Canon Medical Systems Corporation
- 4. Accuray Incorporated
- 5. Brainlab
- 6. Carl Zeiss AG,
- 7. Epic Systems Corporation
- 8. Becton, Dickinson and Company
- 9. Elekta AB (publ)
- More...
Radiotherapy Market Analysis
The global radiotherapy market represents a critical and rapidly expanding segment of the oncology landscape, underpinned by the rising worldwide cancer burden and the essential role of radiation therapy in curative and palliative treatment. The International Agency for Research on Cancer (IARC) estimates approximately 20 million new cancer cases were diagnosed globally in 2025, a figure projected to rise to 22.6 million by 2030 and 34.4 million by 2050. Cancer remains the second leading cause of mortality worldwide, with an estimated 10 million deaths annually. Approximately 50% of all cancer patients have an indication for radiotherapy at some point during their treatment journey, making it a cornerstone of modern oncology. The World Health Organization (WHO) recommends that 50-60% of cancer patients should receive radiotherapy, yet global access remains highly inequitable, with nearly one-third of countries lacking adequate radiotherapy services. According to the research report "Global Radiotherapy Market Outlook, 2031," published by Bonafide Research, the Global Radiotherapy market was valued at more than USD 8.98 Billion in 2025, and expected to reach a market size of more than USD 14.07 Billion by 2031 with the CAGR of 7.97% from 2026-2031. This growth trajectory is driven by the expanding cancer patient population, technological advancements in treatment delivery, and significant government and private sector investment in healthcare infrastructure. North America and Europe currently represent the largest regional markets, while Asia-Pacific is the fastest-growing region, driven by rapid infrastructure expansion in China, India, and Southeast Asia. The global installed base of teletherapy machines is estimated at approximately 12,000–15,000 units as of 2025. External Beam Radiotherapy (EBRT) represents the largest therapy segment globally, driven by the extensive installed base of linear accelerators and the clinical dominance of advanced techniques including IMRT, IGRT, VMAT, and SBRT. Systemic radiotherapy is the fastest-growing therapy segment, fueled by the emergence of novel radiopharmaceuticals and targeted radionuclide therapies. Radiotherapy systems and equipment hold the largest offering segment share, while software and services represent the fastest-growing segment. Breast cancer is the largest application segment, driven by high global incidence rates, while central nervous system and brain cancers are the fastest-growing. Hospitals and integrated cancer centres dominate end-use spending, with academic and research institutions growing fastest. The IAEA's Rays of Hope initiative continues to expand access to radiotherapy in low- and middle-income countries, with 12 Anchor Centres now established across Africa, Asia, Europe, and Latin America.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
• Rising global cancer incidence and aging population: The most fundamental driver of the global radiotherapy market is the substantial and growing cancer burden worldwide. The IARC estimates approximately 20 million new cancer cases were diagnosed in 2025, with projections indicating a 13% increase to 22.6 million by 2030 and a 72% increase to 34.4 million by 2050. The aging global population is a primary contributor, as the risk of cancer increases with age. Approximately one in five people globally will develop cancer before the age of 75. The WHO estimates that 10 million people die from cancer annually, making it the second leading cause of death worldwide. This growing patient population ensures consistent and increasing demand for radiotherapy equipment, software, and comprehensive maintenance services.• Expanding role of radiotherapy in cancer treatment: Approximately 50% of all cancer patients have an indication for radiotherapy at some point during their treatment. The WHO recommends that 50-60% of cancer patients should receive radiotherapy as part of their treatment. In low- and middle-income countries (LMICs), the need for radiotherapy may be even higher due to a more advanced stage of disease at presentation. Radiotherapy contributes approximately 22% to cancer cure rates, second only to surgery (27%). The expanding evidence base for radiotherapy in new indications, including oligometastatic disease and re-irradiation, is further driving demand. The IAEA-led Lancet Oncology Commission projects that the global radiation medicine workforce will need to expand by more than 60% compared to 2022 levels to meet projected demand.
• Technological advancements and precision radiotherapy: Continuous technological innovation is transforming the radiotherapy landscape. The adoption of advanced modalities including IMRT, IGRT, VMAT, SBRT, and proton beam therapy is improving treatment precision and patient outcomes. The integration of artificial intelligence in treatment planning and adaptive radiotherapy is enhancing workflow efficiency and enabling more personalised treatment regimens. MR-guided radiotherapy systems and real-time adaptive platforms represent the frontier of innovation, with the potential to significantly improve tumour control while reducing toxicity. The proton therapy market is experiencing robust growth, driven by the rising global incidence of cancer and increasing demand for highly precise, minimally invasive treatment options.
Market Challenges
• Severe global disparities in radiotherapy access: A profound challenge facing the global radiotherapy market is the extreme inequity in access to radiation therapy services. Radiotherapy remains unavailable in nearly one-third of countries globally, with 28 of these located in Africa. Low-income countries on average need eight times more radiotherapy machines than currently available to meet the target of one machine per 500 patients. More than 2 million cancer patients worldwide are unable to access radiotherapy due to a lack of megavoltage machines (MVMs). In LMICs, up to 70% of cancer patients who would benefit from radiation medicine do not receive this essential curative or pain-relieving treatment. This access gap represents both a humanitarian challenge and a significant market opportunity.• Workforce shortages in radiation oncology: The global shortage of trained radiation oncology professionals is a critical constraint on market growth and service delivery. The IAEA projects that the global radiation medicine workforce will need to expand by more than 60% compared to 2022 levels to meet projected demand. Specific workforce requirements include over 84,000 radiation oncologists, 47,000 medical physicists, and 141,000 radiotherapy technologists. The shortage is particularly acute in LMICs, where training programmes are limited and retention is challenging. The IAEA's Rays of Hope Anchor Centres are addressing this through regional training activities, "train the trainer" workshops, and the development of standardised training programmes.
• High capital costs and infrastructure constraints: The substantial capital investment required for radiotherapy equipment presents a significant barrier, particularly in LMICs. A single linear accelerator system plus installation can exceed USD 5 million. In LMICs, 60-70% of teletherapy machines are more than ten years old or rely on refurbished units. Regulatory clearance timelines for new products (FDA premarket approval and CE marking under MDR) add 18-36 months to new product introductions, limiting the pace of innovation. Semiconductor and high-voltage component shortages have disrupted production, with lead times for key subsystems stretching to 20-30 weeks. These cost and infrastructure constraints limit adoption and create significant demand for refurbished equipment and maintenance services.
Market Trends
• Expansion of proton and heavy-ion therapy centres: The global expansion of proton and heavy-ion therapy infrastructure represents a significant market trend, driven by growing clinical evidence supporting these advanced modalities for specific indications including paediatric cancers, brain tumours, and head and neck cancers. The global proton therapy market is estimated at approximately USD 2.18 billion in 2025, with significant investments underway across the Middle East (Saudi Arabia, UAE), Asia-Pacific (China, South Korea), and Europe (Spain, UK). The IAEA is supporting capacity building for particle therapy through its technical cooperation programme. The rotating proton therapy systems segment dominates the market due to superior flexibility in beam guidance.• Digital transformation and AI integration: The adoption of artificial intelligence and digital technologies is accelerating across global radiotherapy centres. AI is being deployed to enhance treatment planning through automated contouring, dose optimisation, and adaptive replanning, reducing clinician workload and improving consistency. Healthcare providers are investing in enterprise asset management platforms, predictive maintenance capabilities, and AI-powered treatment planning systems to improve efficiency and patient outcomes. The workforce shortage has reinforced the demand for workflow automation and faster AI-supported treatment planning protocols. The IAEA is supporting digital transformation through initiatives such as virtual reality training tools for radiotherapy professionals.
• Local manufacturing and technology localisation: Domestic manufacturing of radiotherapy equipment is emerging as a significant trend, particularly in Asia-Pacific. Chinese manufacturers now supply an estimated 25-30% of new teletherapy units installed in Asia-Pacific, with export volumes to other emerging markets growing at 10-15% annually. India is advancing local LINAC production through the "Make in India" initiative. Domestic manufacturing reduces dependency on international suppliers, lowers equipment costs, and improves access in emerging markets. The trend also creates new demand for local service and maintenance capabilities.
Radiotherapy Segmentation
| By Therapy Type | External Beam Radiotherapy (EBRT) | |
| Internal / Brachytherapy | ||
| Systemic Radiotherapy | ||
| By Offering | Radiotherapy Systems/Equipment | |
| Software & Services | ||
| By Technology | Image-Guided Radiotherapy | |
| Intensity-Modulated Radiotherapy | ||
| Stereotactic Radiosurgery | ||
| Proton Beam Therapy | ||
| 3D-Conformal Radiotherapy | ||
| Volumetric Modulated Arc Therapy | ||
| Other Technology | ||
| By Application | Breast Cancer | |
| Prostate Cancer | ||
| Lung Cancer | ||
| Head & Neck Cancer | ||
| Central Nervous System / Brain | ||
| Gastro-intestinal | ||
| Other Applications | ||
| By End User | Hospitals & Integrated Cancer Centers | |
| Standalone Radiotherapy Centers | ||
| Academic/Research Institutions | ||
| Other Healthcare Facilities | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
External Beam Radiotherapy (EBRT) is the largest therapy segment because the extensive installed base of linear accelerators and the clinical dominance of advanced techniques including IMRT, IGRT, VMAT, and SBRT make it the modality of choice for a broad spectrum of malignancies worldwide. External Beam Radiotherapy (EBRT) represents the largest therapy segment in the global radiotherapy market, driven by the extensive installed base of linear accelerators and the clinical dominance of advanced techniques. EBRT is the modality of choice for a broad spectrum of malignancies due to its effectiveness, non-invasiveness, and well-established evidence base. The global installed base of teletherapy machines is estimated at approximately 12,000–15,000 units as of 2025. Premium-feature segments machines equipped with IGRT, SRS, and MR-guided platforms command a significant share of new-system revenue. Major equipment suppliers including Varian Medical Systems (a division of Siemens Healthineers), Elekta, and Accuray dominate the EBRT segment. Technology upgrade cycles are shortening from 12–15 years to 8–12 years as hospitals adopt hypofractionation, MR-LINACs, and real-time adaptive radiotherapy. Systemic Radiotherapy is the fastest-growing therapy segment because the emergence of novel radiopharmaceuticals and targeted radionuclide therapies is creating new treatment options for specific malignancies, supported by substantial research funding and regulatory frameworks. Systemic Radiotherapy represents the fastest-growing therapy segment in the global radiotherapy market, fueled by the emergence of novel radiopharmaceuticals and targeted radionuclide therapies for treating metastatic prostate cancer, neuroendocrine tumours, and certain lymphomas. The IAEA is supporting the development of nuclear medicine and theranostics capabilities globally, including through its technical cooperation programme and the Rays of Hope initiative. The global radiopharmaceutical market is expanding rapidly, with significant investment in research and development from both pharmaceutical companies and government agencies. This segment is a focal point for innovation and represents a significant area for future market expansion. Radiotherapy Systems/Equipment is the largest offering segment because high capital costs, continuous technological innovation, and the replacement of aging equipment drive substantial investment in treatment delivery systems globally. Radiotherapy Systems/Equipment represents the largest offering segment in the global radiotherapy market, driven by the high capital cost of advanced treatment delivery systems. This includes linear accelerators, proton therapy systems, gamma knives, robotic radiosurgery platforms, and brachytherapy afterloaders. Growth in this segment is sustained by continuous technological innovation, the replacement of aging equipment across the installed base, and the expansion of new cancer centres globally. Premium-feature segments command a significant share of new-system revenue. Annual replacement demand from ageing equipment accounts for a substantial portion of new unit sales. Major suppliers include Varian Medical Systems (Siemens Healthineers), Elekta, Accuray, and IBA (proton therapy). Domestic production in China and India is expanding. Software & Services is the fastest-growing offering segment because the increasing digitalisation of radiation oncology, workforce shortages, and the need for comprehensive lifecycle management are driving demand for advanced software solutions and maintenance services. Software & Services represents the fastest-growing offering segment in the global radiotherapy market, reflecting the increasing digitalisation of radiation oncology. The software component includes advanced treatment planning systems, AI-powered contouring and dose optimisation tools, image registration and fusion platforms, and patient data management systems. The services component encompasses installation, comprehensive maintenance, clinical training, physics support, cybersecurity updates, and remote technical support. After-sales service and consumables contribute a substantial portion of total market revenue and are growing faster than new-system sales as the installed base ages. The trend toward outsourcing maintenance and support services, driven by workforce constraints and the growing complexity of equipment, is a key driver for this segment. Proton Beam Therapy is the fastest-growing technology segment because the expansion of proton therapy infrastructure globally, supported by clinical evidence and investment, is driving significant adoption of this advanced modality. Proton Beam Therapy represents the fastest-growing technology segment in the global radiotherapy market, reflecting the expansion of proton therapy infrastructure worldwide. The global proton therapy market is estimated at approximately USD 2.18 billion in 2025. Proton therapy offers significant advantages for paediatric cancers, brain tumours, and head and neck cancers by reducing dose to surrounding healthy tissues. Rotating proton therapy systems dominate the market due to superior flexibility in beam guidance. The segment is driven by rising global cancer incidence and increasing demand for highly precise, minimally invasive treatment options. Major suppliers include IBA and Varian Medical Systems. Significant investments are underway across North America, Europe, Asia-Pacific, and the Middle East. Breast Cancer is the largest application segment because high global incidence rates and the well-established role of radiotherapy in both breast-conserving therapy and post-mastectomy settings sustain steady demand for treatment equipment and planning software worldwide. Breast Cancer represents the largest application segment in the global radiotherapy market, driven by the high global incidence of breast cancer and the well-established role of radiotherapy in treatment. Breast cancer is the most frequently diagnosed cancer among women globally, sustaining steady demand for treatment equipment and planning software. Techniques including accelerated partial breast irradiation, hypofractionated whole-breast irradiation, and deep inspiration breath-hold are standard practice across the globe. The expansion of screening programmes in both high-income and emerging economies has led to earlier detection, further driving demand for radiotherapy as a component of multidisciplinary care. In LMICs, the need for breast cancer radiotherapy is particularly acute due to later stage at presentation. Central Nervous System / Brain is the fastest-growing application because the use of stereotactic radiosurgery for brain metastases, the development of sophisticated MR-guided radiotherapy for high-grade gliomas, and updated clinical guidelines are driving significant investment in advanced equipment and software globally. Central Nervous System / Brain represents the fastest-growing application in the global radiotherapy market, driven by the use of stereotactic radiosurgery for brain metastases, the development of sophisticated MR-guided radiotherapy for high-grade gliomas, and the publication of updated clinical guidelines. The technological complexity and precision requirements of CNS radiotherapy drive significant investment in advanced equipment and software. Dedicated systems including Gamma Knife and Cyberknife are available across major centres globally. Proton therapy offers significant advantages for paediatric brain tumours and is driving investment in this area. The global proton therapy market identifies brain tumours as a key application segment. Hospitals & Integrated Cancer Centres are the largest end-user segment because these institutions provide comprehensive, multidisciplinary cancer care and possess the infrastructure, capital resources, and clinical expertise to invest in the full range of advanced radiotherapy technologies globally. Hospitals & Integrated Cancer Centres represent the largest end-user segment in the global radiotherapy market, as these institutions provide comprehensive, multidisciplinary cancer care and possess the infrastructure, capital resources, and clinical expertise to invest in the full range of advanced radiotherapy technologies. These organisations often serve as regional referral centres, manage complex and high-acuity cases, and operate the most diverse equipment fleets including multiple LINACs, proton systems, and brachytherapy programmes. In emerging economies, hospitals are the primary recipients of government investment in radiotherapy infrastructure. Academic/Research Institutions are the fastest-growing end-user segment because their central role in advancing the field through clinical trials, technology validation, and workforce training drives high adoption rates of innovative technologies globally. Academic/Research Institutions represent the fastest-growing end-user segment in the global radiotherapy market, reflecting their central role in advancing the field. They conduct clinical trials, develop and test new technologies including FLASH radiotherapy and novel radiopharmaceuticals, validate emerging treatment protocols, and train the next generation of radiation oncologists, medical physicists, and therapists. The IAEA's Rays of Hope Anchor Centres, selected for their clinical excellence, education programmes, and research capacity, serve as critical hubs of expertise and training. Their high adoption rate of innovative technologies makes them a key driver of market growth and a bellwether for broader clinical adoption.
to Download this information in a PDF
Radiotherapy Market Regional Insights
North America dominates the global radiotherapy market because of its advanced healthcare infrastructure, high healthcare expenditure, extensive hospital network, and stringent regulatory requirements that support comprehensive radiotherapy programmes and rapid technology adoption. North America represents the largest regional radiotherapy market, holding a significant share globally. The United States is the dominant country within the region, supported by over 6,100 hospitals, extensive diagnostic imaging networks, and a large installed base of linear accelerators and proton therapy centres (over 40 operating centres). National health spending in the United States is projected to rise from USD 4.8 trillion in 2023 to USD 7.7 trillion by 2032, highlighting the scale of healthcare investment. Canada represents a mature market with a well-established publicly funded healthcare system. Mexico represents an emerging opportunity with rising private healthcare investment and gradual regulatory modernisation through COFEPRIS. North America is expected to remain the dominant regional market through the forecast period. Europe represents a mature but dynamic market with significant investment in infrastructure modernisation across Western, Southern, and Eastern European countries, supported by strong research funding and professional networks. Europe represents the second-largest regional radiotherapy market, accounting for a substantial share of global unit demand. Germany, France, and the United Kingdom are the primary contributors to regional spending, supported by their advanced healthcare systems and large installed bases. The UK's NHS Supply Chain has procured 28 new LINAC systems in 2025/26, delivering savings of £21.8 million. Italy's National Recovery and Resilience Plan (PNRR) has funded 62 linear accelerators valued at approximately €130 million. Spain is advancing deployment of its proton therapy network. The European Union's Horizon Europe programme has allocated USD 5.3 billion to health programmes for 2021-2027, funding research on advanced radiotherapy technologies. Asia-Pacific is the fastest-growing regional market because rapid economic development, large and aging populations, and substantial government investment in healthcare infrastructure are driving significant expansion of radiotherapy capacity across the region. Asia-Pacific represents the fastest-growing regional radiotherapy market, contributing a significant share of global unit demand. China and India are the primary growth engines. China's National Health Commission has approved 42 hospitals to configure heavy-ion proton radiotherapy systems as of December 2025. India faces a significant infrastructure deficit, with only 794 megavoltage machines for a population of 1.45 billion a shortfall of approximately 45% from the minimum required standard. Japan represents a mature market with advanced technology adoption, with the Ministry of Health projecting a 24% increase in radiotherapy demand through 2040. South Korea is emerging as a leader in advanced particle therapy, with health insurance now covering MRI-guided radiotherapy. Australia has added new MBS items for proton beam therapy. Domestic production in China and India is expanding. The Middle East and Africa represent diverse regional markets with significant disparities in infrastructure, from advanced proton therapy centres in GCC countries to severe equipment shortages in sub-Saharan Africa, supported by international initiatives such as the IAEA's Rays of Hope programme. The Middle East and Africa region represents a diverse market with significant disparities in infrastructure and access. Saudi Arabia has launched the first proton therapy centre in the Middle East at King Fahad Medical City. The UAE is developing the region's first heavy-ion therapy facility and proton therapy centre. Egypt is installing its first proton beam therapy facility. However, in Africa, over 20 countries do not have a single radiotherapy machine. Nigeria, with over 223 million people, has only 15 radiotherapy machines. South Africa faces a backlog of nearly 3,000 patients awaiting radiation oncology treatment. The IAEA's Rays of Hope initiative is expanding access through equipment delivery, training, and Anchor Centre designation in Algeria, Egypt, Jordan, Morocco, Qatar, and South Africa. South America represents an emerging regional market with significant growth potential, driven by substantial government investment in radiotherapy infrastructure modernisation, particularly in Brazil and Argentina. South America represents an emerging regional market with significant growth potential. Brazil is the largest market, with INCA estimating approximately 781,000 new cancer cases per year in 2026–2028. The Brazilian government has delivered 22 linear accelerators in 2025, with plans to acquire 121 by 2026. Argentina has announced a significant investment for the Hospital Garrahan, including a paediatric linear accelerator. Colombia faces a deficit of LINACs from IAEA standards, with multiple states lacking any LINACs. Chile requires additional LINACs versus operative units. The IAEA and PAHO continue to support capacity building across the region.
to Download this information in a PDF
Key Development
- June 2026GE HealthCare received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, an AI-enabled auto-contouring solution for radiation therapy planning that includes a Predetermined Change Control Plan. The clearance strengthens regulated pathways for iterative AI updates in planning workflows, supporting broader deployment of automation that reduces manual contouring burden and planning variability across sites.
- May 2026Mevion introduced the S250-FIT proton therapy system to European radiation oncology buyers at ESTRO 2026. The system has FDA clearance and CE marking and is designed to operate inside existing LINAC-vault infrastructure, potentially reducing the capital and construction barriers to proton therapy adoption.
- May 2026GE HealthCare presented updated iRT capabilities, MIM oncology software and workflow integration spanning radiotherapy and theranostics at ESTRO 2026, demonstrating the company's commitment to comprehensive digital oncology solutions.
- May 2026Elekta reported FY2025/26 net sales of approximately USD 1.75 billion, with an adjusted EBIT of approximately USD 215 million and cash flow of approximately USD 146 million. The company projected 2–4% net sales growth for FY2026/27.
- March 2026IBA launched myQA MatriXX AiR, the first wireless 2D ionization chamber array for fast patient-specific quality assurance (QA) in particle therapy, addressing the growing need for efficient QA solutions in proton and heavy-ion therapy centres.
- January 2026Elekta received FDA 510(k) clearance for Evo, bringing AI-enhanced CT imaging and its Iris imaging architecture to the U.S. radiation oncology market, expanding access to advanced imaging capabilities for treatment planning and delivery.
- January 2026RefleXion Medical received FDA clearance for the RefleXion X2 with SCINTIX for primary and metastatic lung and bone tumors. The platform provides a twentyfold increase in PET sensitivity compared with the earlier generation, enabling biology-guided radiotherapy.
- January 2025Mevion Medical delivered the first-ever FIT compact proton therapy system to Stanford Health Care, marking a significant milestone in the commercial deployment of this next-generation compact proton therapy technology.
- September 2025Varian, a Siemens Healthineers company, announced upgraded Halcyon capabilities including enhanced patient positioning, motion management, and HyperSight imaging at ASTRO 2025, further strengthening the system's position in the market.
- September 2025Sumitomo Heavy Industries announced a technical collaboration with Leo Cancer Care (USA) to develop an upright proton therapy system, potentially reducing the cost and footprint of proton therapy facilities.
- September 2025Accuray Inc. introduced Accuray Stellar, an integrated software and hardware solution for automated adaptive radiotherapy in the U.S., enabling real-time treatment adaptation.
- August 2025Accuray Incorporated reported FY2025 revenue of USD 458.5 million, representing a 3% year-over-year increase. The company also improved its operating income to USD 7.8 million, driven by strong radiotherapy system installations and service revenue.
- July 2025Siemens Healthineers expanded a 10-year Value Partnership with Prisma Health, including a USD 50 million investment in cancer care and acquisition of the Varian Ethos adaptive radiotherapy system. The deal underscores provider demand for adaptive platforms and long-term service models that bundle technology refresh, training, and performance commitments into multi-year contracts.
- May 2025GE HealthCare announced FDA clearance of MR Contour DL, enabling AI segmentation of 37 organs and structures for radiotherapy planning, expanding the company's AI-enabled radiotherapy workflow solutions.
Companies Mentioned
- Sumitomo Heavy Industries
- Siemens Healthineers
- Canon Medical Systems Corporation
- Accuray Incorporated
- Brainlab
- Carl Zeiss AG,
- Epic Systems Corporation
- Becton, Dickinson and Company
- Elekta AB (publ)
- RaySearch Laboratories AB
- PTW-Freiburg GmbH
- C-RAD AB
- BEBIG Medical GmbH
- Ion Beam Applications S.A.
- Mevion Medical Systems, Inc.
- Perspective Therapeutics, Inc.
- Shandong Xinhua Medical Instrument Co., Ltd. (SHINVA)
- RefleXion Medical, Inc.
- Hitachi High-Tech Corporation
- Panacea Medical Technologies Pvt. Ltd.
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Global Radiotherapy Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Region
- 6.3. Market Size and Forecast, By Geography
- 6.4. Market Size and Forecast, By Therapy Type
- 6.5. Market Size and Forecast, By Offering
- 6.6. Market Size and Forecast, By Technology
- 6.7. Market Size and Forecast, By Application
- 6.8. Market Size and Forecast, By End User
- 7. North America Radiotherapy Market Outlook
- 7.1. Market Size By Value
- 7.2. Market Share By Country
- 7.3. Market Size and Forecast, By Therapy Type
- 7.4. Market Size and Forecast, By Offering
- 7.5. Market Size and Forecast, By Technology
- 7.6. Market Size and Forecast, By Application
- 7.7. Market Size and Forecast, By End User
- 7.8. United States Radiotherapy Market Outlook
- 7.8.1. Market Size by Value
- 7.8.2. Market Size and Forecast By Therapy Type
- 7.8.3. Market Size and Forecast By Offering
- 7.8.4. Market Size and Forecast By Technology
- 7.8.5. Market Size and Forecast By Application
- 7.8.6. Market Size and Forecast By End User
- 7.9. Canada Radiotherapy Market Outlook
- 7.9.1. Market Size by Value
- 7.9.2. Market Size and Forecast By Therapy Type
- 7.9.3. Market Size and Forecast By Offering
- 7.9.4. Market Size and Forecast By Technology
- 7.9.5. Market Size and Forecast By Application
- 7.9.6. Market Size and Forecast By End User
- 7.10. Mexico Radiotherapy Market Outlook
- 7.10.1. Market Size by Value
- 7.10.2. Market Size and Forecast By Therapy Type
- 7.10.3. Market Size and Forecast By Offering
- 7.10.4. Market Size and Forecast By Technology
- 7.10.5. Market Size and Forecast By Application
- 7.10.6. Market Size and Forecast By End User
- 8. Europe Radiotherapy Market Outlook
- 8.1. Market Size By Value
- 8.2. Market Share By Country
- 8.3. Market Size and Forecast, By Therapy Type
- 8.4. Market Size and Forecast, By Offering
- 8.5. Market Size and Forecast, By Technology
- 8.6. Market Size and Forecast, By Application
- 8.7. Market Size and Forecast, By End User
- 8.8. Germany Radiotherapy Market Outlook
- 8.8.1. Market Size by Value
- 8.8.2. Market Size and Forecast By Therapy Type
- 8.8.3. Market Size and Forecast By Offering
- 8.8.4. Market Size and Forecast By Technology
- 8.8.5. Market Size and Forecast By Application
- 8.8.6. Market Size and Forecast By End User
- 8.9. United Kingdom (UK) Radiotherapy Market Outlook
- 8.9.1. Market Size by Value
- 8.9.2. Market Size and Forecast By Therapy Type
- 8.9.3. Market Size and Forecast By Offering
- 8.9.4. Market Size and Forecast By Technology
- 8.9.5. Market Size and Forecast By Application
- 8.9.6. Market Size and Forecast By End User
- 8.10. France Radiotherapy Market Outlook
- 8.10.1. Market Size by Value
- 8.10.2. Market Size and Forecast By Therapy Type
- 8.10.3. Market Size and Forecast By Offering
- 8.10.4. Market Size and Forecast By Technology
- 8.10.5. Market Size and Forecast By Application
- 8.10.6. Market Size and Forecast By End User
- 8.11. Italy Radiotherapy Market Outlook
- 8.11.1. Market Size by Value
- 8.11.2. Market Size and Forecast By Therapy Type
- 8.11.3. Market Size and Forecast By Offering
- 8.11.4. Market Size and Forecast By Technology
- 8.11.5. Market Size and Forecast By Application
- 8.11.6. Market Size and Forecast By End User
- 8.12. Spain Radiotherapy Market Outlook
- 8.12.1. Market Size by Value
- 8.12.2. Market Size and Forecast By Therapy Type
- 8.12.3. Market Size and Forecast By Offering
- 8.12.4. Market Size and Forecast By Technology
- 8.12.5. Market Size and Forecast By Application
- 8.12.6. Market Size and Forecast By End User
- 8.13. Russia Radiotherapy Market Outlook
- 8.13.1. Market Size by Value
- 8.13.2. Market Size and Forecast By Therapy Type
- 8.13.3. Market Size and Forecast By Offering
- 8.13.4. Market Size and Forecast By Technology
- 8.13.5. Market Size and Forecast By Application
- 8.13.6. Market Size and Forecast By End User
- 9. Asia-Pacific Radiotherapy Market Outlook
- 9.1. Market Size By Value
- 9.2. Market Share By Country
- 9.3. Market Size and Forecast, By Therapy Type
- 9.4. Market Size and Forecast, By Offering
- 9.5. Market Size and Forecast, By Technology
- 9.6. Market Size and Forecast, By Application
- 9.7. Market Size and Forecast, By End User
- 9.8. China Radiotherapy Market Outlook
- 9.8.1. Market Size by Value
- 9.8.2. Market Size and Forecast By Therapy Type
- 9.8.3. Market Size and Forecast By Offering
- 9.8.4. Market Size and Forecast By Technology
- 9.8.5. Market Size and Forecast By Application
- 9.8.6. Market Size and Forecast By End User
- 9.9. Japan Radiotherapy Market Outlook
- 9.9.1. Market Size by Value
- 9.9.2. Market Size and Forecast By Therapy Type
- 9.9.3. Market Size and Forecast By Offering
- 9.9.4. Market Size and Forecast By Technology
- 9.9.5. Market Size and Forecast By Application
- 9.9.6. Market Size and Forecast By End User
- 9.10. India Radiotherapy Market Outlook
- 9.10.1. Market Size by Value
- 9.10.2. Market Size and Forecast By Therapy Type
- 9.10.3. Market Size and Forecast By Offering
- 9.10.4. Market Size and Forecast By Technology
- 9.10.5. Market Size and Forecast By Application
- 9.10.6. Market Size and Forecast By End User
- 9.11. Australia Radiotherapy Market Outlook
- 9.11.1. Market Size by Value
- 9.11.2. Market Size and Forecast By Therapy Type
- 9.11.3. Market Size and Forecast By Offering
- 9.11.4. Market Size and Forecast By Technology
- 9.11.5. Market Size and Forecast By Application
- 9.11.6. Market Size and Forecast By End User
- 9.12. South Korea Radiotherapy Market Outlook
- 9.12.1. Market Size by Value
- 9.12.2. Market Size and Forecast By Therapy Type
- 9.12.3. Market Size and Forecast By Offering
- 9.12.4. Market Size and Forecast By Technology
- 9.12.5. Market Size and Forecast By Application
- 9.12.6. Market Size and Forecast By End User
- 10. South America Radiotherapy Market Outlook
- 10.1. Market Size By Value
- 10.2. Market Share By Country
- 10.3. Market Size and Forecast, By Therapy Type
- 10.4. Market Size and Forecast, By Offering
- 10.5. Market Size and Forecast, By Technology
- 10.6. Market Size and Forecast, By Application
- 10.7. Market Size and Forecast, By End User
- 10.8. Brazil Radiotherapy Market Outlook
- 10.8.1. Market Size by Value
- 10.8.2. Market Size and Forecast By Therapy Type
- 10.8.3. Market Size and Forecast By Offering
- 10.8.4. Market Size and Forecast By Technology
- 10.8.5. Market Size and Forecast By Application
- 10.8.6. Market Size and Forecast By End User
- 10.9. Argentina Radiotherapy Market Outlook
- 10.9.1. Market Size by Value
- 10.9.2. Market Size and Forecast By Therapy Type
- 10.9.3. Market Size and Forecast By Offering
- 10.9.4. Market Size and Forecast By Technology
- 10.9.5. Market Size and Forecast By Application
- 10.9.6. Market Size and Forecast By End User
- 10.10. Colombia Radiotherapy Market Outlook
- 10.10.1. Market Size by Value
- 10.10.2. Market Size and Forecast By Therapy Type
- 10.10.3. Market Size and Forecast By Offering
- 10.10.4. Market Size and Forecast By Technology
- 10.10.5. Market Size and Forecast By Application
- 10.10.6. Market Size and Forecast By End User
- 11. Middle East & Africa Radiotherapy Market Outlook
- 11.1. Market Size By Value
- 11.2. Market Share By Country
- 11.3. Market Size and Forecast, By Therapy Type
- 11.4. Market Size and Forecast, By Offering
- 11.5. Market Size and Forecast, By Technology
- 11.6. Market Size and Forecast, By Application
- 11.7. Market Size and Forecast, By End User
- 11.8. United Arab Emirates (UAE) Radiotherapy Market Outlook
- 11.8.1. Market Size by Value
- 11.8.2. Market Size and Forecast By Therapy Type
- 11.8.3. Market Size and Forecast By Offering
- 11.8.4. Market Size and Forecast By Technology
- 11.8.5. Market Size and Forecast By Application
- 11.8.6. Market Size and Forecast By End User
- 11.9. Saudi Arabia Radiotherapy Market Outlook
- 11.9.1. Market Size by Value
- 11.9.2. Market Size and Forecast By Therapy Type
- 11.9.3. Market Size and Forecast By Offering
- 11.9.4. Market Size and Forecast By Technology
- 11.9.5. Market Size and Forecast By Application
- 11.9.6. Market Size and Forecast By End User
- 11.10. South Africa Radiotherapy Market Outlook
- 11.10.1. Market Size by Value
- 11.10.2. Market Size and Forecast By Therapy Type
- 11.10.3. Market Size and Forecast By Offering
- 11.10.4. Market Size and Forecast By Technology
- 11.10.5. Market Size and Forecast By Application
- 11.10.6. Market Size and Forecast By End User
- 12. Competitive Landscape
- 12.1. Competitive Dashboard
- 12.2. Business Strategies Adopted by Key Players
- 12.3. Key Players Market Share Insights and Analysis, 2025
- 12.4. Key Players Market Positioning Matrix
- 12.5. Porter's Five Forces
- 12.6. Company Profile
- 12.6.1. Siemens Healthineers AG (Varian)
- 12.6.1.1. Company Snapshot
- 12.6.1.2. Company Overview
- 12.6.1.3. Financial Highlights
- 12.6.1.4. Geographic Insights
- 12.6.1.5. Business Segment & Performance
- 12.6.1.6. Product Portfolio
- 12.6.1.7. Key Executives
- 12.6.1.8. Strategic Moves & Developments
- 12.6.2. Elekta AB
- 12.6.3. Accuray Incorporated
- 12.6.4. IBA Worldwide
- 12.6.5. Hitachi High-Tech Corporation
- 12.6.6. Mevion Medical Systems, Inc.
- 12.6.7. Brainlab AG
- 12.6.8. RaySearch Laboratories AB
- 12.6.9. Canon Medical Systems Corporation
- 12.6.10. Carl Zeiss Meditec AG
- 12.6.11. Sumitomo Heavy Industries Ltd.
- 12.6.12. PTW Freiburg GmbH
- 12.6.13. C-RAD AB
- 12.6.14. Panacea Medical Technologies Pvt. Ltd.
- 12.6.15. Shanghai United Imaging Healthcare
- 12.6.16. SHINVA Medical Instrument Co., Ltd.
- 12.6.17. RefleXion Medical, Inc.
- 12.6.18. BEBIG Medical GmbH
- 12.6.19. BD (Becton, Dickinson and Company)
- 12.6.20. Perspective Therapeutics, Inc.
- 13. Strategic Recommendations
- 14. Annexure
- 14.1. FAQ`s
- 14.2. Notes
- 15. Disclaimer
Table 2: Influencing Factors for Radiotherapy Market, 2025
Table 3: Top 10 Counties Economic Snapshot 2024
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Radiotherapy Market Size and Forecast, By Geography (2020 to 2031F) (In USD Billion)
Table 7: Global Radiotherapy Market Size and Forecast, By Therapy Type (2020 to 2031F) (In USD Billion)
Table 8: Global Radiotherapy Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 9: Global Radiotherapy Market Size and Forecast, By Technology (2020 to 2031F) (In USD Billion)
Table 10: Global Radiotherapy Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 11: Global Radiotherapy Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 12: North America Radiotherapy Market Size and Forecast, By Therapy Type (2020 to 2031F) (In USD Billion)
Table 13: North America Radiotherapy Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 14: North America Radiotherapy Market Size and Forecast, By Technology (2020 to 2031F) (In USD Billion)
Table 15: North America Radiotherapy Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 16: North America Radiotherapy Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 17: United States Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 18: United States Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 19: United States Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 20: United States Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 21: United States Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 22: Canada Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 23: Canada Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 24: Canada Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 25: Canada Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 26: Canada Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 27: Mexico Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 28: Mexico Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 29: Mexico Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 30: Mexico Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 31: Mexico Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 32: Europe Radiotherapy Market Size and Forecast, By Therapy Type (2020 to 2031F) (In USD Billion)
Table 33: Europe Radiotherapy Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 34: Europe Radiotherapy Market Size and Forecast, By Technology (2020 to 2031F) (In USD Billion)
Table 35: Europe Radiotherapy Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 36: Europe Radiotherapy Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 37: Germany Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 38: Germany Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 39: Germany Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 40: Germany Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 41: Germany Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 42: United Kingdom (UK) Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 43: United Kingdom (UK) Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 44: United Kingdom (UK) Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 45: United Kingdom (UK) Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 46: United Kingdom (UK) Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 47: France Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 48: France Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 49: France Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 50: France Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 51: France Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 52: Italy Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 53: Italy Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 54: Italy Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 55: Italy Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 56: Italy Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 57: Spain Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 58: Spain Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 59: Spain Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 60: Spain Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 61: Spain Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 62: Russia Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 63: Russia Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 64: Russia Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 65: Russia Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 66: Russia Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 67: Asia-Pacific Radiotherapy Market Size and Forecast, By Therapy Type (2020 to 2031F) (In USD Billion)
Table 68: Asia-Pacific Radiotherapy Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 69: Asia-Pacific Radiotherapy Market Size and Forecast, By Technology (2020 to 2031F) (In USD Billion)
Table 70: Asia-Pacific Radiotherapy Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 71: Asia-Pacific Radiotherapy Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 72: China Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 73: China Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 74: China Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 75: China Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 76: China Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 77: Japan Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 78: Japan Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 79: Japan Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 80: Japan Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 81: Japan Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 82: India Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 83: India Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 84: India Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 85: India Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 86: India Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 87: Australia Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 88: Australia Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 89: Australia Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 90: Australia Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 91: Australia Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 92: South Korea Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 93: South Korea Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 94: South Korea Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 95: South Korea Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 96: South Korea Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 97: South America Radiotherapy Market Size and Forecast, By Therapy Type (2020 to 2031F) (In USD Billion)
Table 98: South America Radiotherapy Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 99: South America Radiotherapy Market Size and Forecast, By Technology (2020 to 2031F) (In USD Billion)
Table 100: South America Radiotherapy Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 101: South America Radiotherapy Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 102: Brazil Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 103: Brazil Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 104: Brazil Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 105: Brazil Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 106: Brazil Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 107: Argentina Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 108: Argentina Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 109: Argentina Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 110: Argentina Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 111: Argentina Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 112: Colombia Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 113: Colombia Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 114: Colombia Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 115: Colombia Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 116: Colombia Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 117: Middle East & Africa Radiotherapy Market Size and Forecast, By Therapy Type (2020 to 2031F) (In USD Billion)
Table 118: Middle East & Africa Radiotherapy Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 119: Middle East & Africa Radiotherapy Market Size and Forecast, By Technology (2020 to 2031F) (In USD Billion)
Table 120: Middle East & Africa Radiotherapy Market Size and Forecast, By Application (2020 to 2031F) (In USD Billion)
Table 121: Middle East & Africa Radiotherapy Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 122: United Arab Emirates (UAE) Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 123: United Arab Emirates (UAE) Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 124: United Arab Emirates (UAE) Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 125: United Arab Emirates (UAE) Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 126: United Arab Emirates (UAE) Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 127: Saudi Arabia Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 128: Saudi Arabia Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 129: Saudi Arabia Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 130: Saudi Arabia Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 131: Saudi Arabia Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 132: South Africa Radiotherapy Market Size and Forecast By Therapy Type (2020 to 2031F) (In USD Billion)
Table 133: South Africa Radiotherapy Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 134: South Africa Radiotherapy Market Size and Forecast By Technology (2020 to 2031F) (In USD Billion)
Table 135: South Africa Radiotherapy Market Size and Forecast By Application (2020 to 2031F) (In USD Billion)
Table 136: South Africa Radiotherapy Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 137: Competitive Dashboard of top 5 players, 2025
Table 138: Key Players Market Share Insights and Analysis for Radiotherapy Market 2025
Figure 2: Market attractiveness Index, By Region 2031F
Figure 3: Market attractiveness Index, By Segment 2031F
Figure 4: Global Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Global Radiotherapy Market Share By Region (2025)
Figure 6: North America Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: North America Radiotherapy Market Share By Country (2025)
Figure 8: US Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 9: Canada Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 10: Mexico Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 11: Europe Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 12: Europe Radiotherapy Market Share By Country (2025)
Figure 13: Germany Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 14: United Kingdom (UK) Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 15: France Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 16: Italy Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 17: Spain Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 18: Russia Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 19: Asia-Pacific Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 20: Asia-Pacific Radiotherapy Market Share By Country (2025)
Figure 21: China Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 22: Japan Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 23: India Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 24: Australia Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 25: South Korea Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 26: South America Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 27: South America Radiotherapy Market Share By Country (2025)
Figure 28: Brazil Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 29: Argentina Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 30: Colombia Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 31: Middle East & Africa Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 32: Middle East & Africa Radiotherapy Market Share By Country (2025)
Figure 33: United Arab Emirates (UAE) Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 34: Saudi Arabia Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 35: South Africa Radiotherapy Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 36: Porter's Five Forces of Global Radiotherapy Market
Radiotherapy Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Our Clients
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (24 August, 2026)
- Notify To Team (24 August, 2026)
- Report updation (25 August, 2026)
- Report Quality Check (25 August, 2026)
- Report Dispatch (26 August, 2026)
- Hard Copy
Recently Viewed Products
Global Radiotherapy Market Outlook, 2031
We are friendly and approachable, give us a call.